We're still accepting applications for fall 2025!
Apply Today
Epidemiologist Abram Wagner discusses why US funding for global vaccination programs benefits Americans through job creation, disease prevention, and economic stability, while building international goodwill and protecting vulnerable populations worldwide.
Five researchers at the University of Michigan School of Public Health have been awarded seed funding to prepare international research projects on a range of global health challenges, including gene therapy ethics, childhood nutrition, national food policy, cholera vaccine allocation, and occupational safety.
Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Aubree Gordon, professor of Epidemiology and Global Public Health, has been awarded a $6.7 million five-year grant to advance her innovative research into influenza immunity development among children.
Elisa Maffioli presented her research about the effect of social influence on vaccination behavior during COVID-19 in Kenya at the Spring 2024 Human Capital Initiative Research Seminar Series.
US flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says University of Michigan School of Public Health researcher Arnold Monto.